Angel Fernando Laureano, M.D.
NPI 1649220609ActiveIndividual· Internal Medicine, Pulmonary Disease· Naranjito, PR
Internal Medicine, Pulmonary Disease (M.D.) in Naranjito, Puerto Rico, trained at University of Puerto Rico School of Medicine (class of 1985). Part D covered 2,848 prescriptions written in 2024, 56% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 5 companies reporting payments in 2025, $581.03 in all, mostly food and beverage.
Overview
| NPI | 1649220609 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | May 11, 2006 |
| Last updated in NPPES | Jul 8, 2014 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Pulmonary Disease Primary | 207RP1001X | 9057 | PR |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Pulmonary Disease (PR) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 2,848 · 3,299 30-day fills |
|---|---|
| Patients | 316 |
| Total drug cost | $352,639 |
| Generic share | 56% of claims |
Education and affiliations
| Medical school | University of Puerto Rico School of Medicine |
|---|---|
| Graduation year | 1985 |
| Medicare specialty | Pulmonary Disease |
| Secondary specialties | Internal Medicine |
Hospital affiliations
- AsemSan Juan, PR
- Hospital Menonita de AibonitoAibonito, PR
Industry payments (Open Payments)
- 2025$581.03 · 8 payments from 5 companies
- 2024$336.29 · 4 payments from 4 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $287.97 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $175.79 | 2 |
| Jazz Pharmaceuticals Inc. | $62.97 | 1 |
| Merck Sharp & Dohme LLC | $39.32 | 1 |
| Chiesi USA, Inc. | $14.98 | 1 |
What the 2025 payments were for
- Food and Beverage$581.03 · 8 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records